Short-term mitomycin C followed by long-term interferon α2β for conjunctiva-cornea intraepithelial neoplasia

Cornea

Volumn 25, Issue 10, 2006, Pages 1220-1223

  Huerva, Valentín ^a,b   Mateo, Antonio J ^a   Mangues, Irene ^a   Jurjo, Carmen ^a  

^a HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^b NONE   (Spain)

Author keywords

Conjunctival and corneal intraepithelial neoplasia; Interferon 2b; Limbal stem cell deficiency; Mitomycin C

Indexed keywords

ALPHA2B INTERFERON; EYE DROPS; MITOMYCIN C;

AGED; ARTICLE; CANCER SURGERY; CASE REPORT; CONJUNCTIVA; CONJUNCTIVA CORNEA INTRAEPITHELIAL NEOPLASIA; CONJUNCTIVA TUMOR; CONSERVATIVE TREATMENT; CORNEA; CORNEA LIMBUS; CORNEA TUMOR; EYE BIOPSY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; PRIORITY JOURNAL; RECURRENT DISEASE; SHORT COURSE THERAPY; STEM CELL;

ADMINISTRATION, TOPICAL; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; CARCINOMA IN SITU; CONJUNCTIVAL NEOPLASMS; CORNEAL DISEASES; EYE NEOPLASMS; FEMALE; HUMANS; INTERFERON ALFA-2B; MITOMYCIN; TREATMENT OUTCOME;

EID: 33845722652     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000240088.38631.46     Document Type: Article

References (24)

1. Shields CL, Shields JA. Tumors of the conjunctiva and cornea. Surv Ophthalmol. 2004;49:3-24.
2. Ramos-Lopez JF, Martinez-Costa R, Cisneros-Lanuza AL, et al. Treatment of conjunctival intraepithelial neoplasia with topical mitomycin C 0,02%. Arch Soc Esp Oftalmol. 2004;79:375-378.
3. Dudney BW, Malecha MA. Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia. Am J Ophthalmol. 2004;137:950-951.
4. Chen C, Louis D, Dodd T, et al. Mitomycin C as an adjunct in the treatment of localised ocular surface squamous neoplasia. Br J Ophthalmol. 2004;88:17-18.
5. Frutch-Pery J, Rozenman Y, Péer J. Topical mitomycin-C for partially excised conjunctival squamous cell carcinoma. Ophthalmology. 2002;109:548-552.
6. Shields CL, Naseripour M, Shields JA. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. Am J Ophthalmol. 2002;133:601-606.
7. Shields CL, Demirci H, Marr BP, et al. Chemoreduction with topical mytomycin C prior to resection of extensive squamous cell carcinoma of the conjuntiva. Arch Ophthalmol. 2005;123:109-113.
8. Toledano N, García S, Díaz D, et al. Interferon alfa 2-B treatment in selected cases of recurrent conjunctival intraepithelial neoplasia. Arch Soc Esp Oftalmol. 2003;78:265-272.
9. Karp CL, Moore JK, Rosa RH Jr. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Ophthalmology. 2001;108:1093-1098.
10. Schechter BA, Schrier A, Nagler RS, et al. Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon Alpha-2b. Cornea. 2002;21:6-11.
11. Boehm MD, Huang AJ. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2 b. Ophthalmology. 2004;111:1755-1761.
12. Di Pascuale MA, Espana E, Tseng SCG. A case of conjunctiva-cornea intraepithelial neoplasia successfully treated with topical mitomycin C and interferon alfa-2b in cycles. Cornea. 2004;23:89-92.
13. Chen HC, Chang SW, Huang SF. Adjunctive treatment with interferon alpha-2b may decrease risk of papilloma-associated conjunctival intraepithelial neoplasia recurrence. Cornea. 2004;23:726-729.
14. Kobayashi A, Yoshita T, Uchiyama K, et al. Successful management of conjunctival intraepithelial neoplasia by interferon alpha-2b. Jpn J Ophthalmol. 2002;46:215-217.
15. Erie JC, Campbell RJ, Leisegang TJ. Conjunctival and corneal intraepithelial and invasive neoplasia. Ophthalmology. 1986;93:176-183.
16. Guthoff R, Lieb WE, Ströbel P, et al. Exenteration of invasive conjunctival squamous cell carcinoma. Br J Ophthalmol. 2004;88:1093-1094.
17. Frucht-Pery J, Rozenmam Y. Mitomycin C therapy for corneal intraepithelial neoplasia. Am J Ophthalmol. 1994;117:164-168.
18. Wilson MW, Hungerford JL, George SM, et al. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Am J Ophthalmol. 1997;124:303-311.
19. Frucht-Pery J, Sugar J, Baum J, et al. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience. Ophthalmology. 1997;104:2085-2093.
20. Dogru M, Erturk H, Shimazaki J, et al. Tear function and ocular surface changes with topical mitomycin (MMC) treatment for primary corneal intraepithelial neoplasia. Cornea. 2003;22:627-639.
21. Chang SW. Early corneal edema following topical application of mitomycin-C. J Cataract Refract Surg. 2004;30:1742-1750.
22. Vann RR, Karp CL. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia. Ophthalmology. 1999;106:91-97.
23. Smith M, Trousdale MD, Rao N, et al. Lack of toxicity of a topical recombinant interferon. Cornea. 1989;8:58-61.
24. McKelvie PA, Daniell M. Impression cytology following mitomycin C therapy for ocular surface squamous neoplasia. Br J Ophthalmol. 2001;85:1115-1119.